Biktarvy’s list price is $4,216 per month. Without insurance, that number can feel impossible. But the reality for most uninsured patients is different: the majority qualify for programs that bring the cost to $0. The problem is rarely eligibility — it’s knowing where to apply, in what order, and exactly what to submit.
This guide covers every program available to uninsured patients in 2026, with step-by-step enrollment instructions, income and eligibility requirements for each, state-specific detail for ADAP, and a clear decision path for patients who have been turned away before.
Do not stop Biktarvy while pursuing assistance. Interrupting antiretroviral therapy can cause viral rebound, immune system decline, and drug resistance mutations that narrow future treatment options. If you cannot afford your next fill, call your prescriber and Gilead’s helpline (1-800-226-2056) today — bridge supplies are available while applications are processed.
Which Program Should You Apply to First?
The right starting point depends on your income, location, and how quickly you need medication. Here is the recommended sequence for an uninsured patient with a valid Biktarvy prescription:
This is the fastest path to a bridge supply while other applications are processed. Gilead can verify preliminary PAP eligibility by phone and initiate a medication bridge. Income up to ~500% FPL. Available in all states.
ADAP is a government program with consistent state oversight — it should run in parallel with Gilead PAP, not as a backup. Find your state program at nastad.org/adap-watch.
If you are in a Medicaid expansion state and earn at or below 138% of the federal poverty level (~$20,800 for a single person in 2026), you may qualify for Medicaid immediately. Apply at healthcare.gov or your state Medicaid agency.
Use findhivcare.hrsa.gov. Ryan White clinics provide HIV care and medications regardless of ability to pay. Many operate 340B pricing programs.
The Patient Advocate Foundation, PAN Foundation, and HealthWell Foundation can supplement or bridge gaps. Apply simultaneously with the above — do not wait for one to be rejected before applying to another.
Program 1: Gilead Advancing Access — Patient Assistance Program (PAP)
Eligibility Requirements
- No adequate prescription drug insurance coverage
- Income generally at or below 500% FPL — approximately $75,300 for a single person in 2026
- Valid, current Biktarvy prescription from a licensed U.S. healthcare provider
- Must be a U.S. resident
Step-by-Step Enrollment
- 1Call 1-800-226-2056 or visit GileadAdvancingAccess.com. A program specialist will assess your situation and determine which program you qualify for.
- 2Request the PAP enrollment forms. Your prescriber’s office must complete the prescriber section.
- 3Gather your income documentation. Acceptable documents include: most recent federal tax return, pay stubs, a Social Security award letter, or a signed income attestation.
- 4Document your insurance status. Provide a letter confirming no coverage, a coverage denial, or a signed attestation that you are uninsured.
- 5Submit the complete package. Incomplete applications are the most common cause of delay. Fax is typically the fastest submission method.
- 6Ask about a bridge supply. Explicitly ask: “Can I receive a bridge supply while my application is being reviewed?”
- 7Follow up at 10 business days. Call 1-800-226-2056 to check status. Have your application reference number ready.
- 8Renew annually. Set a reminder for 60 days before your enrollment ends to begin renewal paperwork.
Program 2: AIDS Drug Assistance Program (ADAP)
General Eligibility Requirements
- Confirmed HIV-positive status (lab documentation required)
- U.S. resident in the state where you are applying
- Income within your state’s ADAP limit
- Uninsured or underinsured
- Valid Biktarvy prescription
State ADAP Income Limits — Selected States (2026)
| State | Income Limit (% FPL) | Approx. Single-Person Limit | Waiting List |
|---|---|---|---|
| California | 500% | ~$75,300 | None |
| New York | 435% | ~$65,511 | None |
| Texas | 200% | ~$30,120 | None (monitor) |
| Florida | 400% | ~$60,240 | None |
| Illinois | 400% | ~$60,240 | None |
| Georgia | 300% | ~$45,180 | None |
| Massachusetts | 500% | ~$75,300 | None |
| New Jersey | 500% | ~$75,300 | None |
Important: State ADAP income limits and waiting list status change during funding cycles. Always verify the current limit directly with your state program at nastad.org/adap-watch before applying.
Program 3: Medicaid
As of 2026, 40 states and DC have adopted Medicaid expansion under the ACA, covering adults earning up to 138% of the federal poverty level (~$20,800 for a single person). States that have NOT adopted Medicaid expansion: Alabama, Florida, Georgia, Kansas, Mississippi, South Carolina, Tennessee, Texas, Wisconsin, and Wyoming.
Program 4: Ryan White Clinics and 340B Pricing
Ryan White clinics cannot turn away a patient due to inability to pay. They frequently participate in the 340B Drug Pricing Program, which allows them to dispense Biktarvy at significantly reduced prices — often at or near $0 for patients without other coverage.
Program 5: ACA Marketplace Coverage With Subsidies
If you are uninsured but earning above Medicaid limits, you may qualify for heavily subsidized ACA Marketplace coverage. Under current law, any person earning between 100% and 400% FPL qualifies for premium tax credits — and some plans are available for $0 in monthly premium after subsidies. Once enrolled, Gilead’s copay card can reduce your Biktarvy cost to $0–$5 per month.
Use the subsidy calculator at kff.org/subsidy-calculator to estimate your premium and out-of-pocket exposure before applying.
Program 6: Nonprofit Copay and Access Foundations
Patient Advocate Foundation (PAF): 1-800-532-5274 | patientadvocate.org
PAN Foundation: 1-866-316-7263 | panfoundation.org
HealthWell Foundation: 1-800-675-8416 | healthwellfoundation.org
NeedyMeds: needymeds.org — free database of patient assistance programs by drug name or location.
Strategy note: Do not wait for one foundation to reject you before applying to another. Apply to all relevant programs simultaneously.
What to Do If Every Program Says No
- Request a written explanation of every denial and ask for a supervisor review if income was calculated incorrectly.
- Ask your prescriber to document medical necessity and financial hardship in a letter to Gilead and your state ADAP.
- Contact your local AIDS service organization (ASO) at hivcare.org for in-person navigation help.
- Contact the Patient Advocate Foundation (1-800-532-5274) for free professional case management.
- Ask your prescriber about a clinical alternative with better access in your specific situation.
Never stop antiretroviral therapy without medical guidance. If you are at risk of imminent treatment interruption, call your prescriber today and tell them explicitly: “I am at risk of missing my next dose due to cost.”
Frequently Asked Questions
Biktarvy’s list price is $4,216 per month as of January 2026. Without insurance or assistance, retail cash prices range from $3,800 to over $5,000. However, the majority of uninsured patients qualify for programs that reduce the cost to $0, including Gilead’s Patient Assistance Program, state ADAP programs, and Ryan White clinics.
The most direct path is Gilead’s Patient Assistance Program — call 1-800-226-2056 or apply at GileadAdvancingAccess.com. You will need proof of income, a valid prescription, and documentation that you lack adequate insurance. State ADAP programs offer a parallel government-funded route. Apply to both simultaneously, not sequentially.
Gilead evaluates PAP eligibility on a case-by-case basis. The published guideline is income up to 500% of the federal poverty level — approximately $75,300 for a single person in 2026 — but Gilead states they review each application individually. Patients above this threshold may still be considered depending on their financial circumstances.
You will need: a completed PAP enrollment form signed by your prescriber; proof of income (recent tax return, pay stubs, or signed attestation); proof of insurance status (documentation of no coverage or a coverage denial); and a current, valid Biktarvy prescription. Gilead’s team at 1-800-226-2056 can walk you through requirements for your specific situation.
ADAP is a state-run, federally funded program under the Ryan White HIV/AIDS Program. Unlike Gilead’s PAP, ADAP is a government program with state oversight and typically provides broader services including lab work and clinic visits. Income limits and eligibility vary by state. The two programs are not mutually exclusive — some patients access both.
Yes. All 50 states, DC, Puerto Rico, Guam, and the U.S. Virgin Islands have ADAP programs. Eligibility criteria, income limits, and waiting list status differ by state. Current status can be checked at NASTAD’s ADAP Watch at nastad.org/adap-watch.
Possibly. If your income is at or below 138% FPL and you live in a Medicaid expansion state, you may qualify immediately. Biktarvy is covered by Medicaid in all states, typically with minimal or no copay. Apply at healthcare.gov or your state Medicaid agency. Medicaid has no enrollment period — you can apply any time.
340B clinics are healthcare facilities that purchase drugs at deeply discounted prices under the federal 340B program and pass those savings to patients. Ryan White clinics, FQHCs, and certain hospitals participate. Patients receiving care at these facilities may access Biktarvy at significantly reduced or no cost through the clinic’s in-house or contract pharmacy.
Processing time is typically 2 to 4 weeks from submission of a complete application. Gilead may offer a bridge supply of medication while your application is being processed. Ask explicitly about bridge medication when you call 1-800-226-2056 or when your prescriber submits the enrollment forms.
Ryan White-funded clinics provide comprehensive HIV care regardless of ability to pay, including prescriptions. Use HRSA’s clinic locator at findhivcare.hrsa.gov to find the nearest facility. Federally Qualified Health Centers (FQHCs) also provide sliding-scale care. Do not delay — HIV treatment is most effective when started promptly.
You must notify Gilead and your ADAP program as soon as your insurance status changes. The Gilead PAP is for uninsured patients — if you gain commercial insurance, you will transition to the copay card program. Failing to report insurance changes can affect eligibility.
Yes. Several states operate supplemental HIV assistance programs — California’s Office of AIDS, New York’s AIDS Institute HIPP program, Texas THMP, Illinois ADAP, New Jersey ADAP, Washington HCAM, and Florida’s HIV/AIDS Section each have programs that extend beyond the base ADAP. Your Ryan White clinic can tell you which programs are available in your state.
Yes, though most nonprofit copay programs are primarily designed for insured patients with high cost-sharing. The Patient Advocate Foundation, PAN Foundation, and HealthWell Foundation may cover uninsured patients in some circumstances. Fund availability fluctuates — apply to multiple programs simultaneously and ask about waitlists if a fund is closed.
Your Complete Action List
- Call Gilead Advancing Access: 1-800-226-2056 — ask about PAP eligibility and bridge supply today
- Find your state ADAP program at nastad.org/adap-watch and start enrollment simultaneously
- Check Medicaid eligibility at healthcare.gov/screener if your income is below ~$20,800 (single)
- Find the nearest Ryan White clinic at findhivcare.hrsa.gov
- Apply to PAF: patientadvocate.org or 1-800-532-5274
- Apply to PAN Foundation: panfoundation.org or 1-866-316-7263
- Apply to HealthWell Foundation: healthwellfoundation.org or 1-800-675-8416
- Find your local AIDS service organization at hivcare.org
- Do not stop Biktarvy without medical guidance — tell your prescriber if cost is a barrier
How we reviewed this article:
Sunny Pharma follows strict sourcing guidelines and relies on peer-reviewed studies, government agencies (FDA, CMS, HRSA), academic research institutions, and medical associations. We use only credible, verifiable sources to ensure accuracy.
Read our editorial policy →Sources & References
- Gilead Advancing Access — Patient Assistance: gileadadvancingaccess.com
- Gilead Price Info — Biktarvy WAC: gileadpriceinfo.com
- HRSA — Ryan White HIV/AIDS Program: ryanwhite.hrsa.gov
- NASTAD — ADAP Watch: nastad.org/adap-watch
- HRSA — Find HIV Care Locator: findhivcare.hrsa.gov
- HRSA — 340B Drug Pricing Program: hrsa.gov
- Medicaid.gov — Eligibility: medicaid.gov
- Patient Advocate Foundation: patientadvocate.org
- PAN Foundation: panfoundation.org
- HealthWell Foundation: healthwellfoundation.org
- FDA — Biktarvy Prescribing Information: accessdata.fda.gov